Research map: Rethinking lymphodepleting preconditioning in adoptive T cell therapy for durable tumor control

Back to the article

Papers in this map

  1. Adoptive cell transfer as personalized immunotherapy for human cancer · Steven A. Rosenberg · 2015 · 2547 citations · Cited by this paper
  2. CAR design equips diverse immune cells with unique antigen-specific activation identities · Ayano Sugiyama-Finnis · 2026 · Related
  3. Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma · Mark E. Dudley · 2005 · 1641 citations · Cited by this paper
  4. Depletion of IL-10 in CAR-NK cells augments reprogramming of the tumor microenvironment and ameliorates therapeutic efficacy · 2026 · Related
  5. Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy · Stefani Spranger · 2017 · 1470 citations · Cited by this paper
  6. AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer · 2026 · Related
  7. Tumor Antigen Escape from CAR T-cell Therapy · Robbie G. Majzner · 2018 · 1213 citations · Cited by this paper
  8. CART-immune-related adverse events after BCMA CAR-T therapy · 2026 · Related
  9. Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma · Martin Lauss · 2017 · 511 citations · Cited by this paper
  10. Unmasking Wnt-driven HCC: Inhibiting SMYD2 to overcome immune resistance · 2026 · Related
  11. Cellular networks controlling T cell persistence in adoptive cell therapy · Jack D. Chan · 2021 · 247 citations · Cited by this paper
  12. Intraperitoneal delivery of the oncolytic virus CF17 improves tumor immunogenicity and survival in gastric cancer peritoneal metastasis · 2026 · Related
  13. Endogenous T cells prevent tumor immune escape following adoptive T cell therapy · Scott R. Walsh · 2019 · 111 citations · Cited by this paper
  14. Synergistic Cell-Cycle Repression by HDAC/EZH2 Co-Targeting in H3K27-Altered Diffuse Midline Glioma · 2026 · Related
  15. Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 + T-myeloid cell networks in melanoma · David Barras · 2024 · 97 citations · Cited by this paper
  16. Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity · 2026 · Related
  17. Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse · Luca Gattinoni · 2026 · 11 citations · Cited by this paper
  18. Optimizing CAR T cell therapy in pancreatic cancer through clinically actionable combinations · 2026 · Related
  19. Lymphodepleting preconditioning impairs host antitumor immunity induced by adoptive T cell therapy in mouse models · Diego A. Figueroa · 2026 · 2 citations · Cited by this paper
  20. Strategies to prevent HNSCC by chewing gum delivery of enzymes/antimicrobials to reduce carcinogenic acetaldehyde produced by pathogenic microbes · 2026 · Related

Source: OpenAlex (CC0)